Literature DB >> 31036565

Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.

Shubhi Pandey1, Xaria X Li2, Ashish Srivastava1, Mithu Baidya1, Punita Kumari1, Hemlata Dwivedi1, Madhu Chaturvedi1, Eshan Ghosh1, Trent M Woodruff3, Arun K Shukla4.   

Abstract

The human complement component, C5a, binds two different seven-transmembrane receptors termed C5aR1 and C5aR2. C5aR1 is a prototypical G-protein-coupled receptor that couples to the Gαi subfamily of heterotrimeric G-proteins and β-arrestins (βarrs) following C5a stimulation. Peptide fragments derived from the C terminus of C5a can still interact with the receptor, albeit with lower affinity, and can act as agonists or antagonists. However, whether such fragments might display ligand bias at C5aR1 remains unexplored. Here, we compare C5a and a modified C-terminal fragment of C5a, C5apep, in terms of G-protein coupling, βarr recruitment, endocytosis, and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase activation at the human C5aR1. We discover that C5apep acts as a full agonist for Gαi coupling as measured by cAMP response and extracellular signal-regulated kinase 1/2 phosphorylation, but it displays partial agonism for βarr recruitment and receptor endocytosis. Interestingly, C5apep exhibits full-agonist efficacy with respect to inhibiting lipopolysaccharide-induced interleukin-6 secretion in human macrophages, but its ability to induce human neutrophil migration is substantially lower compared with C5a, although both these responses are sensitive to pertussis toxin treatment. Taken together, our data reveal that compared with C5a, C5apep exerts partial efficacy for βarr recruitment, receptor trafficking, and neutrophil migration. Our findings therefore uncover functional bias at C5aR1 and also provide a framework that can potentially be extended to chemokine receptors, which also typically interact with chemokines through a biphasic mechanism.
© 2019 Pandey et al.

Entities:  

Keywords:  G-protein–coupled receptor (GPCR); arrestin; cell signaling; complement; signal transduction

Mesh:

Substances:

Year:  2019        PMID: 31036565      PMCID: PMC6579481          DOI: 10.1074/jbc.RA119.007485

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The genetic design of signaling cascades to record receptor activation.

Authors:  Gilad Barnea; Walter Strapps; Gilles Herrada; Yemiliya Berman; Jane Ong; Brian Kloss; Richard Axel; Kevin J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

2.  Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.

Authors:  Nathan Robertson; Mathieu Rappas; Andrew S Doré; Jason Brown; Giovanni Bottegoni; Markus Koglin; Julie Cansfield; Ali Jazayeri; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

3.  Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.

Authors:  Daniel E Croker; Peter N Monk; Reena Halai; Geraldine Kaeslin; Zoe Schofield; Mike Cl Wu; Richard J Clark; Mark At Blaskovich; Dimitrios Morikis; Christodoulos A Floudas; Matthew A Cooper; Trent M Woodruff
Journal:  Immunol Cell Biol       Date:  2016-04-25       Impact factor: 5.126

4.  Arrestins as rheostats of GPCR signalling.

Authors:  J Silvio Gutkind; Evi Kostenis
Journal:  Nat Rev Mol Cell Biol       Date:  2018-10       Impact factor: 94.444

5.  GloSensor assay for discovery of GPCR-selective ligands.

Authors:  Boda Arun Kumar; Poonam Kumari; Chandan Sona; Prem N Yadav
Journal:  Methods Cell Biol       Date:  2017-09-11       Impact factor: 1.441

6.  Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.

Authors:  M Kawai; D A Quincy; B Lane; K W Mollison; Y S Or; J R Luly; G W Carter
Journal:  J Med Chem       Date:  1992-01-24       Impact factor: 7.446

7.  Measuring surface expression and endocytosis of GPCRs using whole-cell ELISA.

Authors:  Shubhi Pandey; Debarati Roy; Arun K Shukla
Journal:  Methods Cell Biol       Date:  2018-11-19       Impact factor: 1.441

8.  A Practical Guide to Approaching Biased Agonism at G Protein Coupled Receptors.

Authors:  Jaimee Gundry; Rachel Glenn; Priya Alagesan; Sudarshan Rajagopal
Journal:  Front Neurosci       Date:  2017-01-24       Impact factor: 4.677

Review 9.  Genome Editing Provides New Insights into Receptor-Controlled Signalling Pathways.

Authors:  Graeme Milligan; Asuka Inoue
Journal:  Trends Pharmacol Sci       Date:  2018-03-13       Impact factor: 14.819

10.  Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Authors:  Vernon Seow; Junxian Lim; Adam J Cotterell; Mei-Kwan Yau; Weijun Xu; Rink-Jan Lohman; W Mei Kok; Martin J Stoermer; Matthew J Sweet; Robert C Reid; Jacky Y Suen; David P Fairlie
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

View more
  9 in total

1.  Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo.

Authors:  Declan M Gorman; Xaria X Li; Colton D Payne; Cedric S Cui; John D Lee; K Johan Rosengren; Trent M Woodruff; Richard J Clark
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-17

2.  Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.

Authors:  Abdulraman M Alshammari; D David Smith; Jake Parriott; Jason P Stewart; Stephen M Curran; Russell J McCulloh; Peter A Barry; Smita S Iyer; Nicholas Palermo; Joy A Phillips; Yuxiang Dong; Donald R Ronning; Jonathan L Vennerstrom; Sam D Sanderson; Joseph A Vetro
Journal:  ACS Infect Dis       Date:  2020-04-13       Impact factor: 5.084

3.  Key phosphorylation sites in GPCRs orchestrate the contribution of β-Arrestin 1 in ERK1/2 activation.

Authors:  Mithu Baidya; Punita Kumari; Hemlata Dwivedi-Agnihotri; Shubhi Pandey; Madhu Chaturvedi; Tomasz Maciej Stepniewski; Kouki Kawakami; Yubo Cao; Stéphane A Laporte; Jana Selent; Asuka Inoue; Arun K Shukla
Journal:  EMBO Rep       Date:  2020-07-26       Impact factor: 9.071

4.  Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21.

Authors:  Bhavani S Sahu; Pedro Rodriguez; Megin E Nguyen; Ruijun Han; Cheryl Cero; Maria Razzoli; Paolo Piaggi; Lauren J Laskowski; Mihaela Pavlicev; Louis Muglia; Sushil K Mahata; Scott O'Grady; John D McCorvy; Leslie J Baier; Yuk Y Sham; Alessandro Bartolomucci
Journal:  Cell Rep       Date:  2019-09-03       Impact factor: 9.423

5.  Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors.

Authors:  Shubhi Pandey; Punita Kumari; Mithu Baidya; Ryoji Kise; Yubo Cao; Hemlata Dwivedi-Agnihotri; Ramanuj Banerjee; Xaria X Li; Cedric S Cui; John D Lee; Kouki Kawakami; Jagannath Maharana; Ashutosh Ranjan; Madhu Chaturvedi; Gagan Deep Jhingan; Stéphane A Laporte; Trent M Woodruff; Asuka Inoue; Arun K Shukla
Journal:  Mol Cell       Date:  2021-09-27       Impact factor: 19.328

6.  The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.

Authors:  Xaria X Li; Vinod Kumar; Richard J Clark; John D Lee; Trent M Woodruff
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

7.  Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.

Authors:  Peter W West; Rajia Bahri; Karen M Garcia-Rodriguez; Georgia Sweetland; Georgia Wileman; Rajesh Shah; Angeles Montero; Laura Rapley; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

8.  Submolecular probing of the complement C5a receptor-ligand binding reveals a cooperative two-site binding mechanism.

Authors:  Andra C Dumitru; R N V Krishna Deepak; Heng Liu; Melanie Koehler; Cheng Zhang; Hao Fan; David Alsteens
Journal:  Commun Biol       Date:  2020-12-18

9.  Purification of native CCL7 and its functional interaction with selected chemokine receptors.

Authors:  Marina V Goncharuk; Debarati Roy; Maxim A Dubinnyi; Kirill D Nadezhdin; Ashish Srivastava; Mithu Baidya; Hemlata Dwivedi-Agnihotri; Alexander S Arseniev; Arun K Shukla
Journal:  Protein Expr Purif       Date:  2020-03-05       Impact factor: 1.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.